ATE400813T1 - Tumormarker für frühes krebsstadium - Google Patents

Tumormarker für frühes krebsstadium

Info

Publication number
ATE400813T1
ATE400813T1 AT00957049T AT00957049T ATE400813T1 AT E400813 T1 ATE400813 T1 AT E400813T1 AT 00957049 T AT00957049 T AT 00957049T AT 00957049 T AT00957049 T AT 00957049T AT E400813 T1 ATE400813 T1 AT E400813T1
Authority
AT
Austria
Prior art keywords
early stage
tumor markers
stage cancer
urine
blood
Prior art date
Application number
AT00957049T
Other languages
English (en)
Inventor
Takashi Muramatsu
Kohji Okamoto
Shinya Ikematsu
Munehiro Oda
Hideshi Kumai
Sadatoshi Sakuma
Original Assignee
Takashi Muramatsu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takashi Muramatsu filed Critical Takashi Muramatsu
Application granted granted Critical
Publication of ATE400813T1 publication Critical patent/ATE400813T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00957049T 1999-09-10 2000-09-08 Tumormarker für frühes krebsstadium ATE400813T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25667899 1999-09-10
JP34540499 1999-12-03
JP2000033168 2000-02-10

Publications (1)

Publication Number Publication Date
ATE400813T1 true ATE400813T1 (de) 2008-07-15

Family

ID=27334550

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00957049T ATE400813T1 (de) 1999-09-10 2000-09-08 Tumormarker für frühes krebsstadium

Country Status (9)

Country Link
US (1) US7090983B1 (de)
EP (1) EP1215500B1 (de)
KR (1) KR100768985B1 (de)
CN (1) CN1232826C (de)
AT (1) ATE400813T1 (de)
AU (1) AU780957B2 (de)
CA (1) CA2384579C (de)
DE (1) DE60039441D1 (de)
WO (1) WO2001020333A1 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003301348A1 (en) * 2002-10-18 2004-05-04 Wyeth Compositions and methods for diagnosing and treating autoimmune disease
US20100022414A1 (en) 2008-07-18 2010-01-28 Raindance Technologies, Inc. Droplet Libraries
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
WO2004092992A1 (ja) * 2003-04-15 2004-10-28 Cell Signals Inc. 健康情報の提供システムおよび健康情報の提供方法
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
WO2007053659A2 (en) * 2005-11-01 2007-05-10 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Method of screening for hepatocellular carcinoma
EP1984738A2 (de) 2006-01-11 2008-10-29 Raindance Technologies, Inc. Mikrofluidische vorrichtungen und verfahren zur verwendung bei der bildung und kontrolle von nanoreaktoren
KR100777088B1 (ko) 2006-04-04 2007-11-28 재단법인 한국원자력의학원 간암을 진단하기 위한 마커인 ｌｃｎ2, ｍｉｄｋｉｎｅ 및ｔｆｐｉ, 그를 포함하는 키트 및 상기 마커를 이용한 간암예측 방법
EP4190448A3 (de) 2006-05-11 2023-09-20 Bio-Rad Laboratories, Inc. Mikrofluidische vorrichtungen
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
US9012390B2 (en) 2006-08-07 2015-04-21 Raindance Technologies, Inc. Fluorocarbon emulsion stabilizing surfactants
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
JPWO2009025094A1 (ja) * 2007-08-20 2010-11-18 大野　典也 哺乳動物の癌の診断方法
JP5580205B2 (ja) * 2007-11-19 2014-08-27 セレラ コーポレーション 肺癌マーカーとその使用
EP2261660B1 (de) * 2008-02-29 2013-08-07 National University Corporation Nagoya University Biomarker zur abschätzung von akuter nierenkrankheit und prognose der krankheit sowie verwendung des biomarkers
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
US20100221752A2 (en) * 2008-10-06 2010-09-02 Somalogic, Inc. Ovarian Cancer Biomarkers and Uses Thereof
JP2010139293A (ja) * 2008-12-10 2010-06-24 Medical Therapies Ltd 早期癌腫瘍マーカー
US8528589B2 (en) 2009-03-23 2013-09-10 Raindance Technologies, Inc. Manipulation of microfluidic droplets
WO2010143423A1 (ja) * 2009-06-10 2010-12-16 国立大学法人 新潟大学 糖尿病性腎症の検査方法
EP2486409A1 (de) 2009-10-09 2012-08-15 Universite De Strasbourg Markiertes nanomaterial auf siliziumbasis mit verbesserten eigenschaften und seine verwendung
EP2517025B1 (de) 2009-12-23 2019-11-27 Bio-Rad Laboratories, Inc. Verfahren zur reduzierung des austauschs von molekülen zwischen tröpfchen
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
EP4435111A1 (de) 2010-02-12 2024-09-25 Bio-Rad Laboratories, Inc. Digitale analytanalyse
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
CA2801110C (en) 2010-07-09 2021-10-05 Somalogic, Inc. Lung cancer biomarkers and uses thereof
CN106198980B (zh) 2010-08-13 2018-09-07 私募蛋白质体公司 胰腺癌生物标记及其用途
WO2012045012A2 (en) 2010-09-30 2012-04-05 Raindance Technologies, Inc. Sandwich assays in droplets
NZ589251A (en) * 2010-11-12 2014-07-25 Pacific Edge Ltd Novel marker for detection of bladder cancer
US9364803B2 (en) 2011-02-11 2016-06-14 Raindance Technologies, Inc. Methods for forming mixed droplets
EP2675819B1 (de) 2011-02-18 2020-04-08 Bio-Rad Laboratories, Inc. Zusammensetzungen und verfahren für molekulare etikettierung
WO2012167142A2 (en) 2011-06-02 2012-12-06 Raindance Technolgies, Inc. Enzyme quantification
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
EP2823303A4 (de) 2012-02-10 2015-09-30 Raindance Technologies Inc Molekulardiagnostischer screeningtest
WO2013165748A1 (en) 2012-04-30 2013-11-07 Raindance Technologies, Inc Digital analyte analysis
US9946887B2 (en) 2012-06-04 2018-04-17 Nokia Technologies Oy Method and apparatus for determining privacy policy based on data and associated values
CN104956224B (zh) 2012-11-20 2017-12-12 美国政府卫生与公共服务部 测量中期因子或多效生长因子水平用于诊断生长的测定
US20140271453A1 (en) * 2013-03-14 2014-09-18 Abbott Laboratories Methods for the early detection of lung cancer
EP2986762B1 (de) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digitale analyse von analyten
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
WO2015103367A1 (en) 2013-12-31 2015-07-09 Raindance Technologies, Inc. System and method for detection of rna species
WO2015182218A1 (ja) * 2014-05-26 2015-12-03 オリンパス株式会社 膵癌判定方法
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
CN109387635A (zh) * 2018-11-07 2019-02-26 国家纳米科学中心 基于热泳细胞外囊泡检测的胃癌检测系统及方法
KR20220000082U (ko) 2020-07-01 2022-01-10 박세현 곽 휴지 형 그림책

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3842304B2 (ja) * 1992-10-08 2006-11-08 喬 村松 癌の診断、治療薬
JP3418416B2 (ja) * 1992-10-08 2003-06-23 喬 村松 核酸診断法
WO2000031541A2 (en) * 1998-11-20 2000-06-02 Georgetown University Method of detecting neurofibromatosis type 1

Also Published As

Publication number Publication date
US7090983B1 (en) 2006-08-15
WO2001020333A1 (en) 2001-03-22
EP1215500A4 (de) 2004-12-08
CN1390304A (zh) 2003-01-08
CA2384579A1 (en) 2001-03-22
KR100768985B1 (ko) 2007-10-22
EP1215500B1 (de) 2008-07-09
CA2384579C (en) 2010-12-07
CN1232826C (zh) 2005-12-21
AU780957B2 (en) 2005-04-28
KR20020043577A (ko) 2002-06-10
AU6876000A (en) 2001-04-17
DE60039441D1 (de) 2008-08-21
EP1215500A1 (de) 2002-06-19

Similar Documents

Publication Publication Date Title
ATE400813T1 (de) Tumormarker für frühes krebsstadium
NZ595684A (en) Urine markers for detection of bladder cancer
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
DK1078264T3 (da) Tumormarkörer
WO2006081473A3 (en) Methods for diagnosis and prognosis of epithelial cancers
EP1260176A3 (de) Arrayanordnung und Verfahren zur Lokalisierung einer In-Vivo-Signalquelle
ATE440629T1 (de) Kanüleneinführungssystem
ATE322014T1 (de) Krebsnachweisverfahren und reagenzien
WO2004060302A3 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
DE59911849D1 (de) Messgerät in art eines zirkels, insbesondere zur verwendung in der medizintechnik
DE60041623D1 (de) Körperstützsystem für Patienten
WO2004112567A3 (en) Methods, device and system for in vivo detection
DE60239042D1 (de) Haptene, Immunogene, Antikörper und Konjugate für 2-oxo-3-hydroxy LSD
DE60234821D1 (de) Messverfahren für vollblut
WO2007041383A3 (en) Endoscopic imaging device
DE69906202D1 (de) Evakuiertes Blutentnahmeröhrchen zur schneller Blutgerinnung
EP1610127A4 (de) N1,n12-diacetylspermin als tumormarker
DK1214447T3 (da) Påvisning af pyruvatkinase-isoenzymer i fæces
DE60031471D1 (de) Verzweiger zur Verwendung mit einem optischen Verstärker
FR2774579B1 (fr) Sonde, notamment sonde vaginale
ATE409002T1 (de) Gerät für prostatekrebsdiagnose
ATE277197T1 (de) Nachweis von harnblasenkarzinom in einer urinprobe
CN217645390U (zh) 一种用于胆管支架精准定位的输送装置
EP1115426A4 (de) Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungenund hodenkrebs
AU2002366555A1 (en) Diagnostic for early stage alzheimer's disease

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties